Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker - Wikidata - awgldk - TriplyDB

Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker

Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker

http://www.wikidata.org/entity/Q24601670

about

Cannabinoids for epilepsy Cannabinoids for epilepsy Cannabinoids for epilepsy Multifunctional drugs for head injury Use of magnesium in traumatic brain injury Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy.Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.The therapeutic potential of the cannabinoids in neuroprotection.Novel therapies in development for the treatment of traumatic brain injury.Influence of cannabinoids on the delayed rectifier in freshly dissociated smooth muscle cells of the rat aorta.The therapeutic potential of cannabinoids for movement disorders.Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling.Recent advances in the development of multifactorial therapies for the treatment of traumatic brain injury.Pharmacology of traumatic brain injury: where is the "golden bullet"?Endocannabinoids: A Promising Impact for Traumatic Brain Injury.Acute management of acquired brain injury part II: an evidence-based review of pharmacological interventions.Cannabinoids, multiple sclerosis and neuroprotection.Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic.Crystal structures of agonist-bound human cannabinoid receptor CB1.Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke.Recent advances in epilepsy.Effects of cannabinoids and related fatty acids upon the viability of P19 embryonal carcinoma cells.Slim evidence for cannabinoids for epilepsy.Neuropharmacology and therapeutic potential of cannabinoids.A systemic administration of NMDA induces immediate early gene pip92 in the hippocampus.Modulation of neurotransmission by cannabinoids in the basal ganglia.Novel telomerase-increasing compound in mouse brain delays the onset of amyotrophic lateral sclerosis Attempts of ranking in a series of synthetic nonpsychotropic cannabinoids.Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioural symptoms.Effects of the cannabinoid CB1 agonist ACEA on salicylate ototoxicity, hyperacusis and tinnitus in guinea pigs.Psychiatric morbidity in ketamine users attending counselling and youth outreach services.Medial prefrontal cortex N-methyl-D-aspartate receptor/nitric oxide/cyclic guanosine monophosphate pathway modulates both tachycardic and bradycardic baroreflex responses.Synthesis, radio-synthesis and in vitro evaluation of terminally fluorinated derivatives of HU-210 and HU-211 as novel candidate PET tracers.Serial examination of serum IL-8, IL-10 and IL-1Ra levels is significant in neonatal seizures induced by hypoxic-ischaemic encephalopathy.Medial prefrontal cortex endocannabinoid system modulates baroreflex activity through CB(1) receptors.Polyamines induce blood-brain barrier disruption and edema formation in the rat.Perioperative Management of Severe Traumatic Brain Injury: What Is New?

P2860

Q24198048-2FD5C718-2F2C-4DFF-955B-623A8F2F6D14 Q24202656-1997CAD9-AE2C-41D0-AFA9-0C2C5AC70192 Q24235307-8BB1C17C-A07F-40D8-B450-EAE31278AB81 Q30371428-141F47F0-45D9-425E-9177-E8422D649600 Q34096651-58B3BFB7-4EAF-40B5-B6C1-62286DBCE868 Q34459205-0226B041-7F07-4AAB-B01D-1DDA2BA0A798 Q34490167-92567CFD-A6EE-43DB-99A1-32CF0180C9F4 Q34974856-9F3F1574-3169-4631-90EA-419791B965DF Q34974860-3CAF0AB7-18D4-4BDE-AF65-9953363CF686 Q35042648-AF1F1569-4B14-485B-9790-DE876EEE70B4 Q35171113-959D8203-2D14-4BFE-BA5A-BD311E090307 Q35684044-67E51A99-B27B-4A47-9ED5-4B3326AF912C Q35906957-C56C5781-9C0A-4A3F-A0A3-EFAFB4F189B6 Q37260316-2E0996B8-AD62-471B-A3DE-0E563864B1F4 Q37648343-26C75643-09C0-4671-8E8A-ED8A63AD7E84 Q37727119-9ECDEDD4-3A99-4D03-85B2-78EFBAFCE38A Q37960199-37DB8562-C548-457B-9C48-41E6A80C9B01 Q38196398-31ABF58C-9C11-4B54-A6DE-16F097374D9C Q38430121-D34415D9-1EAB-49A6-8C7D-3DFF1ED43F93 Q38974387-D88E9AA7-B785-498A-B82D-F2826A795EDE Q39000942-A7D1826F-F1A5-4531-B3A5-753868AC0977 Q39172074-AAD8C812-734C-4DCE-9A68-F07CB3396345 Q40226550-9CEBCA98-CB66-406C-97C3-16C9E519D0B3 Q40784670-07957B92-B53F-4E33-89FB-AA49E92EB0D5 Q40873850-03125DC4-F80F-4705-A996-95AE673E889F Q41371378-E1FF2067-643D-4B2B-81AB-4CB0E104B24F Q41875894-4C1FB024-6577-433B-9A0D-58AF79153128 Q43791056-230E5DB0-48FB-4241-B2FD-AF70EC55AAD3 Q43815277-5CA10DE6-34A1-4F39-99F1-FA9FF03F6B4D Q47107982-950711E4-E542-4F08-809A-2FE84644DFD9 Q47844005-26910A9B-DA6A-49E6-A2F1-A5617A874698 Q47862410-C8D468E9-AED2-4082-BA2C-744AD7C02510 Q48225409-D2CEE167-9C59-4E8B-8410-89E2104D6A88 Q48547335-21E9FE35-8B0A-41E1-B625-7B79EA90F800 Q48743600-B15D4D2C-F669-48E3-BF10-75A23BBE1ED5 Q50753767-0F35DAD1-EE82-42C6-A8D0-88ED7385856A Q58782096-94F5A4B0-FA94-4415-93DA-A234ABDE911E

P2860

Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker

http://www.wikidata.org/entity/Q24601670

description

1989 nî lūn-bûn

@nan

1989 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1989 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1989年の論文

@ja

1989年論文

@yue

1989年論文

@zh-hant

1989年論文

@zh-hk

1989年論文

@zh-mo

1989年論文

@zh-tw

1989年论文

@wuu

name

Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker

@ast

Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker

@en

Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker

@nl

type

label

Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker

@ast

Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker

@en

Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker

@nl

prefLabel

Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker

@ast

Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker

@en

Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker

@nl

P1433

Q24601670-E0450904-80D0-455E-823C-83F8DA792443

P1476

Q24601670-97A20CDC-540E-4143-BC9F-F3817A4EEFE1

P2093

Q24601670-07AB8D1A-2350-4F22-B712-9CBB9EB1DE70

Q24601670-60BB06D9-FE8F-403C-B396-A96906E77F3F

Q24601670-9B595398-5C4D-45D8-A60E-EBD88BBB9CCE

Q24601670-D8E37BEC-5B80-4779-84E1-E07592A548F3

Q24601670-F138BB87-1B7E-4B3A-B97B-EE2FA1749EC9

Q24601670-F2FBED94-2F78-4E4A-B6D0-47B2E3E53D71

P2860

Q24601670-143BA1F9-8BEC-40C7-BCB9-E84714744CC8

Q24601670-4F8EAEDA-0850-467C-BB14-ABF2CE060D44

Q24601670-52292438-1B57-42FA-A233-A7DB8B0E22AC

Q24601670-54291ED3-70E2-41FE-8B3A-38171671B23A

Q24601670-5677309F-2DD0-4A69-95E6-03AB93CEC842

Q24601670-75249094-6E87-4A68-8C1D-CC9D316250F9

Q24601670-7C464E8C-5153-413E-AE7D-7AE9ACF81A5A

Q24601670-862B61BA-8FF0-4350-B8A1-31211A3E32FA

Q24601670-95C78A60-0BCE-429C-BD8D-821EBDE7DA43

Q24601670-993AAE35-C302-4FC5-B886-A3C1B6F6B797

P304

Q24601670-FB3E980A-643D-4D4B-976F-A0B26D22657C

P31

Q24601670-895AA19D-0726-4933-A973-3D811D4DF3C0

P356

Q24601670-E0939298-BF1E-407C-B117-1D1E5196F1ED

P407

Q24601670-1930855C-7D86-4CDA-8CEE-7A1DDDEF2880

P433

Q24601670-E5D1A140-3346-4EA3-AB03-45CF84D073AC

P478

Q24601670-1C73351B-804D-465E-ADC7-2885B65F24B8

P50

Q24601670-28A9B77D-55E9-48E7-A4DC-C2C1349BBD91

P577

Q24601670-64925F1D-D2F0-4A0C-80DA-9E8ADEFF0272

P5875

Q24601670-4982C2F4-A97F-4352-BD0E-1F8DD8546859

P698

Q24601670-69FC5EFE-9DEC-4999-98E5-1E0FF47A9115

P921

Q24601670-62dc0684-1cdd-4dd3-a780-c554eb0c8d6b

Q24601670-CE444DD4-FA04-4F71-A206-C19A4328D3E3

Q24601670-F51C617F-5DED-4B76-B617-6FFD31AA7690

P932

Q24601670-725B585F-A917-4D42-AA2E-84E9F01785BE

P356

PNAS.86.23.9584

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker

@en

P2093

F Bergmann

http://www.w3.org/2001/XMLSchema#string

J J Feigenbaum

http://www.w3.org/2001/XMLSchema#string

M Sokolovsky

http://www.w3.org/2001/XMLSchema#string

S A Richmond

http://www.w3.org/2001/XMLSchema#string

V Nadler

http://www.w3.org/2001/XMLSchema#string

Y Kloog

http://www.w3.org/2001/XMLSchema#string

P2860

Coexpression of N-methyl-D-aspartate and phencyclidine receptors in Xenopus oocytes injected with rat brain mRNA

Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes.

Enantiomeric cannabinoids: stereospecificity of psychotropic activity.

The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate.

Glutamate neurotoxicity and diseases of the nervous system.

Tricyclic antidepressants block N-methyl-D-aspartate receptors: similarities to the action of zinc.

Glutamate and the pathophysiology of hypoxic--ischemic brain damage.

Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity.

The effect of drugs altering striatal dopamine levels on apomorphine induced stereotypy.

Towards cannabinoid drugs.

P304

9584-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.86.23.9584

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P50

Raphael Mechoulam

P577

1989-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20598872

http://www.w3.org/2001/XMLSchema#string

P698

2556719

http://www.w3.org/2001/XMLSchema#string

P921

cannabinoid receptor

P932

298542

http://www.w3.org/2001/XMLSchema#string